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Abstract The chemokine receptor CXCR4 and its endog-
enous ligand, CXCL12, are involved in development and
homeostasis of the central nervous system and in the
neuropathology of various neuroinflammatory/infectious
disorders, including neuroAIDS. Our previous studies have
shown that CXCR4 regulates cell cycle proteins that affect
neuronal survival, such as the retinoblastoma protein, Rb.
These studies also suggested that Rb-mediated gene
repression might be involved in the neuronal protection
against NMDA exitotoxicity conferred by stimulation of the
CXCL12/CXCR4 axis. In order to further test this
hypothesis, we focused on the potential interaction of Rb
with another protein implicated in regulation of gene
expression, leucine-rich acidic nuclear protein (Lanp), also
known as ANP32A/pp32/PHAP1. Lanp is a critical
member of the protein complex inhibitor of histone acetyl
transferase (INHAT), which prevents histone tail's acetyla-
tion, thus leading to transcriptional repression. Our data
show that, in primary rat cortical neurons cultured for up to
30 days, Lanp is predominantly localized into the nucleus
throughout the culture period, in line with in vivo evidence.
Moreover, co-immunoprecipitation experiments show that
endogenous Lanp interacts with Rb in neurons. Stimulation
of CXCR4 by its endogenous ligand, CXCL12, increased
Lanp protein levels in these neurons. Importantly, the effect
of CXCL12 was preserved after exposure of neurons to
NMDA. Finally, overexpression of exogenous Lanp in the
neurons protects them from excitotoxicity. Overall, these
findings suggest that Lanp can interact with Rb in both
young and mature neurons and is implicated in the
regulation of neuronal survival by CXCL12/CXCR4.
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Introduction
The chemokine receptor CXCR4 and its endogenous ligand
CXCL12 are expressed constitutively in the central nervous
system (CNS) during development and adulthood and play
important roles in physiology and pathology (Li and
Ransohoff 2008). The CXCL12/CXCR4 axis has been
implicated in important neuronal functions, such as mod-
ulation of neurotransmission, differentiation, and survival
(Guyon and Nahon 2007; Li and Ransohoff 2008).
Stimulation of CXCR4 by its natural ligand CXCL12
activates different signaling pathways in neurons (Li and
Ransohoff 2008). Previous studies from our group have
shown that CXCR4 also controls specific cell cycle
regulators such as p53 and the cdk-Rb-E2F pathway in
postmitotic neurons (Khan et al. 2005; Shimizu et al. 2007;
Khan et al. 2008). These proteins may be involved in
transcriptional regulation of specific sets of genes that affect
the survival of postmitotic neurons independently of their
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this, our findings indicate that CXCR4 positively regulates
Rb and this controls the expression of E2F1 pro-apoptotic
targets in neurons, thus resulting in neuroprotection (Khan
et al. 2003; Shimizu et al. 2007; Khan et al. 2008).
Interestingly, non-physiological ligands of CXCR4 that
induce abnormal stimulation of CXCR4, such as the HIV-1
envelope protein gp120IIIB, are unable to stimulate Rb
function and induce neurotoxicity via E2F-dependent path-
ways (Shimizu et al. 2007; Bachis et al. 2009). This further
supports the role of Rb in neuroprotection and highlights
the importance of proper function of the CXCL12/CXCR4
axis in the CNS.
Rb is able to bind more than 100 different proteins, some
of which directly or indirectly control cell fate (Morris and
Dyson 2001). These interactions determine the various
specific roles of Rb in a cell. Rb mostly acts as a gene
suppressor and interacts with well-known transcription
factors (e.g., E2F1), as well as enzymes regulating the
post-translational modifications of histones (Macaluso et al.
2006). These chromatin modifications favor chromatin
condensation, thus inhibiting gene expression by limiting
access of transcription complexes to the DNA. Among the
Rb-interacting proteins that regulate transcriptional activity,
ANP32a/Lanp (also known as pp32, PHAP1, I1PP2A;
henceforth referred to as Lanp in this paper) is also found in
neurons (Matsuoka et al. 1994; Adegbola and Pasternack
2005). It belongs to a family of leucine-rich repeats-
containing proteins (Matilla and Radrizzani 2005). Lanp is
an integral component of the inhibitor of histone acetyl
transferase complex (INHAT), which blocks transcription
by masking N-terminal histone tails from the activity of
histone acetyl transferases or through interaction with
histone deacetylases (Seo et al. 2001; Seo et al. 2002).
Recent studies indicate that, through its INHAT activity,
Lanp is involved in both physiological and pathological
processes in the CNS (Matilla and Radrizzani 2005). One
example is its ability to regulate expression of neurofila-
ment genes in neurons, which affects neuronal differentia-
tion (Kular et al. 2009). Furthermore, alterations of Lanp
functions have been implicated in spinocerebellar ataxia
type 1 (SCA1) and Alzheimer's disease (Matilla et al. 1997;
Chen et al. 2008). However, the precise role of Lanp in
neuronal survival is still unclear. Furthermore, while its
interaction with Rb prevents cell death (Adegbola and
Pasternack 2005), studies in proliferating cells indicate that
Lanp can also be involved in apoptosis (Jiang et al. 2003;
Pan et al. 2009).
Our earlier studies demonstrate that Rb plays a central
role in the neuroprotective functions of CXCL12/CXCR4
(Khan et al. 2008). Given the reported interaction of Lanp
and Rb in non-neuronal cells (Adegbola and Pasternack
2005), we asked whether they may also interact in neurons
supporting their survival. Here, we examined the constitu-
tive and CXCL12-stimulated expression of endogenous
Lanp in primary neuronal cultures at different stages of
differentiation, its interaction with Rb, and the effect of
Lanp overexpression on excitotoxicity. Our data show for
the first time a protective role of this nuclear Rb partner in
postmitotic neurons.
Materials and methods
Neuronal cultures Cortical neurons were obtained from the
brains of 17-day-old rat fetuses and cultured in a serum-free
medium using the bilaminar cell culture system (Banker
and Cowan 1977; Kaech and Banker 2006), in which pure
neuronal cultures are grown in the presence of a separate
glial feeder layer supporting their growth and differentia-
tion. This model reproduces, to a certain extent, the in vivo
environment (i.e., the presence of neuronal and non-
neuronal cells) and offers the major advantage that neurons
can be separated from the glia at any time in order to
analyze neuron-specific biological responses. We have
extensively used the bilaminar culture system to study
expression and function of chemokine receptors in neurons,
including CXCR4, and previously demonstrated that the
signaling pathways induced by direct activation of neuronal
CXCR4 promote neuronal survival mechanisms, even in
the absence of glia (Khan et al. 2004; Sengupta et al. 2009).
In these studies, unless otherwise noted, CXCL12 treat-
ments (20 nM) were performed in the presence of glia in
order to predict the potential outcome of CXCL12
stimulation in vivo. Neurons were always separated from
the glia immediately before protein extraction. Cortical
neurons were plated on poly-L-lysine-coated 15-mm cover-
slips (40×10
3 or 50×10
3 cells) or 60-mm dishes (1×10
6
cells)—depending on the type of experiment. Treatments
started after at least 7 days in vitro (7 DIV).
Immunocytochemistry Neurons were fixed in 4% parafor-
maldehyde. For neuronal marker staining, anti-β tubulin III
(clone TUJ1, 1:500, from Covance, Berkeley, CA, USA)
was used, followed by a cy3-conjugated (Fig. 1) or a cy2-
conjugated secondary antibody (Fig. 5a). For Lanp staining,
anti-Lanp (C-18, 1:200, Santa Cruz Biotechnology, Santa
Cruz, CA, USA) was followed by a biotin-conjugated
secondary antibody and then by cy3-streptavidin. To
visualize FLAG-Lanp-expressing neurons (Fig. 5a), a
DYKDDDDK Tag antibody that detects FLAG (cat#
2368, 1:800, Cell Signaling Technology, Danvers, MA,
USA) was used followed by a cy3-conjugated secondary
antibody (Fig. 5a). Nuclear staining was obtained using
Hoechst 33342 (0.5 μl/ml). Cells were observed under an
epifluorescent microscope (Olympus IX70, Melville, NY,
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USA), and images were taken using Metamorph software
(Molecular Devices, Sunnyvale, CA, USA).
Western blots For total cell lysates, neurons were scraped in
lysis buffer (25 mM Tris, 150 mM NaCl, 5 mM NaF, 1 mM
EDTA, 1 mM DTT, 1% IGEPAL-CA-630, 5 mg each of
aprotinin, leupeptin, and pepstatin, 1 mM AEBSF, and
1 mM vanadate), as reported previously (Shimizu et al.
2007; Khan et al. 2008). The protein concentration of cell
lysates was determined using the bicinchoninic acid assay
from Pierce (Rockford, IL, USA). Equal amounts of
proteins (25 μg) were loaded in each lane, separated by
SDS-PAGE and transferred to PVDF membranes for
immunoblotting. The following primary antibodies were
used: anti-Lanp (C-18, 1:1,000; Santa Cruz Biotechnology),
anti-Rb (1:4,000,G3-245; BD Biosciences PharMingen,
Franklin Lakes, NJ, USA), and anti-Actin (1:5,000,
A2066; Sigma-Aldrich, St. Louis, MO, USA). Bands were
detected by chemiluminescence using the Pierce Super-
Signal West Femto maximum sensitivity kit, according to
the manufacturer's instructions, and analyzed using the
FluorChem 8900 apparatus from Alpha Innotech (San
Leandro, CA, USA).
Immunoprecipitation For immunoprecipation (IP), 250 μg
protein was used for each treatment (Fig. 3). IP reactions
were performed with goat anti-Lanp or monoclonal
anti-Rb antibodies and ExactaCruz™ B (sc-45039), or
ExactaCruz™ A reagents (sc-45038, Santa Cruz Bio-
technology), respectively, were used, according to the
manufacturer's protocols. The precipitated extracts were
immunoblotted and probed for Lanp and Rb proteins as
described above.
Fig. 1 Expression of Lanp in
primary cortical neurons: Neu-
rons were cultured for 1–
30 days as reported in the
methods section, then fixed
and stained for endogenous
Lanp (green) using a specific
antibody. The neuronal marker
β tubulin III (red) was used for
visualization of neuronal cell
bodies while the nuclei were
stained with Hoechst 33342
(blue). Scale bar =5 0μm
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cortical neurons (50 × 10
3 cells per coverslip) were
divided in two groups. One group was transfected with
pFLAG-Lanp vector (expressing murine Lanp; a gift from
Dr. Huda Zoghby, Baylor College of Medicine, Houston,
TX, USA), whereas the other group was transfected with a
control plasmid expressing GFP; the Lipofectamine 2000
reagent (Invitrogen, Carlsbad, CA, USA) was used for
transfection (4 μg of plasmid per coverslip). NMDA
neurotoxicity assay was conducted as described before
(Khan et al. 2008); only the cells expressing GFP and
those positive to FLAG immunostaining were counted
(Fig. 5). Transfection efficiency in these experiments was
about 35%.
Materials Unless otherwise specified, tissue culture media
are from Invitrogen. CXCL12 (SDF-1α) was purchased
from PeproTech (Rocky Hill, NJ, USA); the chemokine
was reconstituted in PBS/0.1% BSA, stored as stock
solution at −20°C, and used at a final concentration of
20 nM. AMD3100 was obtained from Sigma-Aldrich,
reconstituted in water, and used at final concentrations of
100 ng/ml.
Statistical analysis Student's t test or ANOVA (followed by
Newman–Keuls multiple comparison test) were used for
statistical analysis (P<0.05 was considered statistically
significant). All data are reported as mean ± SEM. Experi-
ments were performed at least three times.
Results
Expression of Lanp protein in cortical neurons and its
regulation by the chemokine CXCL12 Recent ex vivo
studies have shown that Lanp is expressed predominantly
in the neuronal nuclei in distinct regions of the brain
(Kovacech et al. 2007). However, earlier studies in
neuronal cell lines have suggested the possibility of
subcellular translocation (i.e., from nucleus to cytosol) of
Lanp upon differentiation (Opal et al. 2003). In order to
determine intracellular localization of Lanp in primary
neuronal cultures, immunostaining of Lanp was performed
on rat cortical neurons cultured for up to 4 weeks (Fig. 1).
At all the time periods studied (from 1 to 30 days), Lanp
was found to be expressed mainly in the neuronal nuclei,
and no increase in the cytosolic levels of the protein was
observed upon neuronal differentiation and maturation at
any time (Fig. 1). Thus, Lanp expression in our primary
cultures reflects the in vivo situation; these data also
suggest that the expression of the protein in neuronal cell
lines may be altered and/or influenced by the cell cycle.
OurpreviousstudiesindicatethatCXCR4isabletocontrol
Rbtranscriptionalactivity(Khanetal.2008). We have shown
that RNAi-mediated Rb depletion in cortical neurons leads
to the disruption of CXCR4-mediated protection against
neurotoxicity (Khan et al. 2008). Lanp is known to interact
with Rb, and this interaction is implicated in the regulation
of cell survival in different cell lines (Adegbola and
Pasternack 2005). To determine whether the CXCL12/
CXCR4 axis can also regulate Lanp protein levels, differen-
tiated rat cortical neurons were treated with CXCL12 (20 nM
for 30 min) and protein extracts collected after 3–5h —in
analogy to our studies with Rb. Western blot analysis
showed an increase in the endogenous Lanp protein in
treated neurons (Fig. 2a). Pre-treatment with the CXCR4-
antagonist, AMD3100 (100 ng/ml, added to the culture
medium before CXCL12), abolished the up-regulation of
Lanp by CXCR4, confirming the involvement of CXCR4
activity in this effect (Fig. 2a). Overall, these data indicate
that CXCR4 stimulation regulates Lanp in cortical neurons.
Interaction of Lanp with Rb and its involvement in CXCL12
neuroprotection In order to determine whether Lanp inter-
acts with Rb in neurons, IP studies were performed in
cortical neuronal extracts using specific antibodies against
Lanp or Rb. Immunoprecipitates were then probed by
Western blots for both of these proteins individually
(Fig. 3). These experiments indicate that endogenous Rb
and Lanp co-immunoprecipitate, suggesting that they
constitutively interact in neurons (Fig. 3). Next, we asked
whether Lanp may be involved in the CXCL12 neuro-
protective effect along with Rb; based on our previous
studies concerning the regulation of Rb by CXCL12 and its
consequences on neuronal survival (Khan et al. 2008), we
predicted that CXCL12 would be able to up-regulate Lanp
levels in control, as well as NMDA-treated, neurons. To test
this hypothesis, neurons were treated with CXCL12 and/or
NMDA (100 μM for 20 min) as we previously reported
(Khan et al. 2008). Cell extracts were collected after 5 h,
immunoblotted, and probed for Lanp. As expected,
CXCL12 was able to increase Lanp protein levels in both
control and NMDA-treated neurons (Fig. 4).
Role of Lanp in neuroprotection against NMDA exitotox-
icity To study the role of Lanp in neuronal survival, we
used a Lanp expression vector (Fig. 5a), in which the Lanp
sequence is fused with FLAG tag at N-terminal (Matilla et
al. 1997). Expression of this vector in primary cortical
neurons led to Lanp localization to the nucleus similar to
endogenous Lanp (Fig. 5a). Moreover, Flag–Lanp did not
affect cell survival under basal conditions (Fig. 5b), in
contrast to findings in proliferating cells (Jiang et al. 2003;
Pan et al. 2009). To explore if Lanp could protect neurons
from excitotoxicity, neurons transfected with the same
166 J Neuroimmune Pharmacol (2011) 6:163–170vector were treated with NMDA (100 μM for 20 min) and
neuronal death assessed 24 h later; a set of control neurons
transfected with a GFP expression vector that underwent
the same NMDA treatment was used for comparison. In our
previously published studies, this NMDA protocol has shown
Fig. 3 EndogenousLanpinteractswithRbinneurons:Equalamountsof
neuronal extracts (250 μg; 9DIV) were incubated with either anti-Rb or
anti-Lanp before electrophoresis/immunoblotting for both Rb and Lanp.
A specific IgG mixture was used as immunoprecipitation control
Fig. 2 CXCL12 increases endogenous Lanp levels in cortical
neurons: Rat cortical neurons were treated with CXCL12 (20 nM)
for 30 min; total cell extracts were collected at 3–5 h after treatment
and immunoblotted for Lanp and actin (a). Equal amounts of protein
(25 μg) were loaded in each lane. Densitometric analysis of three
independent experiments is reported in the graph (A) as mean±SEM
of band density units (asterisk, P<0.05 vs control; n=3). The
immunoblots on the bottom (B) are from additional studies with
neurons treated with the specific CXCR4 antagonist, AMD 3100
(100 ng/ml). AMD was added to the culture 15 min before exposure to
CXCL12 (20 nM, 5 h); at the end of the treatment, total cell lysates
were extracted and immunoblotted for Lanp and actin. The graph (B)
represents the densitometric analysis of three independent experiments
(asterisk, P<0.05 vs CXCL12)
Fig. 4 Effect of CXCL12 and NMDA on neuronal Lanp: Vehicle- or
CXCL12-treated neurons were stimulated with NMDA (100 μM for
20 min); neuronal extracts were collected after 5 h and immunobotted
for Lanp and actin. Densitometric analysis of three independent
experiments is reported in the graph as mean±SEM of band density
units (asterisk, P<0.05 vs NMDA; n=3)
J Neuroimmune Pharmacol (2011) 6:163–170 167to induce 60% to 70% neuronal death (Patel et al. 2006). As
opposed to NMDA-treated GFP-expressing cells, Lanp-
expressing cells were significantly protected from NMDA
neurotoxicity (P<0.001). This is the first evidence of a
protective role of Lanp in neurons.
Discussion
This report lends support to the role of CXCL12/
CXCR4 axis in the control of neuronal survival and
adds Lanp to the list of modulators of gene expression
that are regulated by CXCR4. Furthermore, our data
suggest that Lanp might be involved in CXCL12/
CXCR4 neuroprotection from excitotoxicity (Fig. 6).
Lanp belongs to a family of evolutionarily conserved
proteins that have leucine-rich repeats in their N-termini
(Matilla and Radrizzani. 2005). These motifs are in-
volved in its interaction with a variety of other proteins,
and these interactions determine the range of its functions
in a specific cell type. Its acidic C-terminus contains the
nuclear localization signal (Pan et al. 2009).
In this report, we observe that, in primary cortical
neurons, native Lanp is expressed predominantly and
abundantly in the nucleus throughout neuronal differentia-
tion. Thus, the subcellular translocation of Lanp as shown
by an earlier study in a differentiating neuronal cell line
seems to be limited to that specific cell line, since all other
evidence, including this paper, argues against it being a
common mechanism in CNS (Opal et al. 2003; Kovacech et
al. 2007). Interestingly, previous studies in proliferating
cells have shown that cytosolic Lanp is involved in
pathways that affect cell survival. For example, cytosolic
Lanp is involved in granzyme A-induced death of
cytotoxic T-lymphocyte target cells, or, in other cells,
it is a part of a specific complex that promotes
formation and function of apoptosome resulting in
caspase-mediated cell death (Fan et al. 2003;J i a n ge t
al. 2003; Pan et al. 2009). On the contrary, in postmitotic
neurons, Lanp is primarily expressed in the nucleus, can
interact with other endogenous nuclear proteins, such as
Rb, and promote neuronal survival. Lanp is an essential
part of the INHAT complex and, as a result, it is involved
in binding to and, thus, masking the N-terminal histone
tails from histone acetyl transferase activity (Seo et al.
2001; Seo et al. 2002). Hence, Lanp acts mainly as a gene
repressor. Recent studies in neuronal cells indicate that
Lanp interacts with a transcriptional repressor, E4F, and
enhances its activity, further supporting the nuclear role
for Lanp in neurons (Cvetanovic et al. 2007). Moreover, in
the context of neurodegenerative disorders, the mutated
ataxin-1, which has been implicated in spinocerebellar
ataxia type 1 (SCA1), is able to relieve Lanp-E4F gene
repression by competing with Lanp for binding to E4F;
these interactions might lead to SCA1 neuropatholgy in
cerebellum (Cvetanovic et al. 2007). The present study
shows that the chemokine CXCL12 positively regulates
neuronal Lanp. Considering the interaction of endogenous
Lanp with Rb, these data suggest that Lanp might be
Fig. 5 Overexpression of Lanp protects neurons from NMDA
toxicity: Neurons were transfected with a Flag–Lanp expression
vector (pFlagLanp). The exogenous Lanp was visualized by anti-
FLAG antibody (a). Cells were also stained for a neuronal marker, β
tubulin III (green) and Hoechst 33342 to visualize nuclei (blue). Scale
bar =5 0μm. Neurons transfected either with control pGFP vector or
pLanp vector were treated with NMDA (100 μM, 20 min) and fixed
after 24 h to determine cell survival. FLAG–LANP-expressing
neurons were visualized by immunocytochemistry and data collected
from three independent experiments is expressed as mean±SEM in the
graph (b). Asterisk, P vs NMDA (pLanp) <0.001
Fig. 6 A schematic diagram showing the CXCL12/CXCR4-mediated
signaling events leading to the putative formation of Lanp-Rb gene
repressor complex and its effect on neuronal survival
168 J Neuroimmune Pharmacol (2011) 6:163–170involved in CXCR4-regulated Rb signaling in neurons.
Our previous studies implicate Rb and Rb-mediated gene
repression in the neuroprotection action of CXCL12
(Khan et al. 2008). Novel data also show that CXCL12
reduces in vitro/in vivo expression of specific neuronal
genes, namely, the NR2B subunit of NMDA receptor,
normally controlled by HDAC/Rb-dependent mechanisms
(Nicolai et al. 2010;Q i ua n dG h o s h2008). As a result of
the limited expression of NR2B, CXCL12 would be able
to control calcium entry via extrasynaptic NMDA recep-
tor, thus preventing excitotoxicity (Nicolai et al. 2010).
The findings reported in the present paper suggest that
Lanp might be one of the Rb-interacting proteins involved
in neuronal survival in response to NMDA insult.
In agreement with this conclusion, when Lanp is over-
expressed in cortical neurons, it retains its nuclear locali-
zation and protects neurons against NMDA toxicity.
Overall, these results suggest that Lanp acts as an Rb-
interacting protein in neurons and may play a significant
role in neuronal survival in vivo. These data are in line
with other reports showing that Lanp regulates the
promoter of the neurofilament light chain (NF-L) gene
through inhibition of histone acetylation, and it is thus
implicated in neurite outgrowth (Kular et al. 2009).
Interestingly, CXCR4 stimulation leads to comparable
effects during CNS development and differentiation
(Pujol et al. 2005). It is possible that Lanp mediates
some of these effects. Unfort u n a t e l y ,w ew e r eu n a b l et o
provide direct evidence about this in the present study as
depletion of Lanp in these neurons by shRNA resulted in
major alterations of neuronal differentiation, in agreement
with and in addition to the previous studies (Kular
et al. 2009; Suppl. Figs. 1 and 2). Thus, NMDA-induced
neurotoxicity was negligible in these cultures (not
shown). Further investigations using conditional knock-
out of Lanp or alternative approaches may be necessary to
address this issue.
In conclusion, our results show that CXCL12 positively
regulates nuclear expression of Lanp, which may act in
concert with Rb to ultimately reduce excitotoxicity (Fig. 6).
Although further studies are required to determine the
molecular mechanisms involved in the regulation of Lanp
by CXCR4 and its direct link to neuroprotection, our data
raise the possibility that Lanp, along with Rb, contributes to
suppression of specific genes that play a critical role in
neuronal survival and differentiation.
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